Dr Mark Stephen Neumann, DO in Lambertville, MI - General Practice

Dr Mark Stephen Neumann, DO is a General Practice physician based in Lambertville, Michigan. Dr Mark Stephen Neumann is licensed to practice in Michigan (license number 5101013724) and his current practice location is 8745 Secor Rd, Lambertville, Michigan. He can be reached at his office (for appointments etc.) via phone at (419) 787-3883.

NPI number for Dr Mark Stephen Neumann is 1831226398 and his current mailing address is 8745 Secor Rd, Lambertville, Michigan. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831226398.

Contact Information

	Dr Mark Stephen Neumann, DO
	8745 Secor Rd, Lambertville, MI 48144-9793
	(419) 787-3883
	Not Available

Physician's Profile

Full Name	Dr Mark Stephen Neumann
Gender	Male
Speciality	General Practice
Location	8745 Secor Rd, Lambertville, Michigan
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1831226398
Provider Enumeration Date: 02/28/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Mark Stephen Neumann such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831226398	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	5101013724 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark Stephen Neumann is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark Stephen Neumann, DO 8745 Secor Rd, Lambertville, MI 48144-9793 Ph: (419) 787-3883	Dr Mark Stephen Neumann, DO 8745 Secor Rd, Lambertville, MI 48144-9793 Ph: (419) 787-3883

News Archive

CNIO team generates transgenic mouse model for aplastic anaemia associated with short telomeres

Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.

Researchers to use $6.3M grant to develop novel therapeutic approaches for pediatric sarcomas

Researchers at Nationwide Children's Hospital will use a $6.3 million grant to further their study of pediatric sarcomas, a rare form of the disease that affects bone or soft tissue and accounts for 11 percent of all childhood cancers.

Assistant Sec. of Health Koh addresses AIDS 2012 plenary; HHS Sec. Sebelius speaks at Washington Post event

Speaking at the plenary session of the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., on Monday, U.S. Assistant Secretary for Health Howard Koh discussed the development and implementation of the United States' first-ever comprehensive National HIV/AIDS Strategy, ABC News reports.

Biomimicry could be promising approach for accelerating sustainable product innovation

A case study, "Biomimicry: Streamlining the Front End of Innovation for Environmentally Sustainable Products," shows that biomimicry, a relatively new field that seeks to emulate nature to find solutions to human problems, can potentially expand intellectual property, increase energy savings and accelerate product innovation.

Dr Mark Stephen Neumann, DO - General Practice in Lambertville, MI